SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-009990
Filing Date
2024-03-29
Accepted
2024-03-29 11:00:59
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A nby20231231_10ka.htm   iXBRL 10-K/A 174036
2 EXHIBIT 31.1 ex_647372.htm EX-31.1 3899
3 EXHIBIT 31.2 ex_647369.htm EX-31.2 3996
4 EXHIBIT 32.1 ex_647370.htm EX-32.1 4467
5 EXHIBIT 32.2 ex_647371.htm EX-32.2 4103
  Complete submission text file 0001437749-24-009990.txt   411009

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20231231.xsd EX-101.SCH 3401
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20231231_def.xml EX-101.DEF 17402
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20231231_lab.xml EX-101.LAB 23725
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20231231_pre.xml EX-101.PRE 18442
21 EXTRACTED XBRL INSTANCE DOCUMENT nby20231231_10ka_htm.xml XML 6709
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33678 | Film No.: 24802575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)